| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/28/1997 | WO1997023228A3 Contraceptive process and kit for female mammals, comprising a combination of gestagen and oestrogen |
| 08/28/1997 | WO1997022624A3 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
| 08/28/1997 | WO1997022346A3 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances |
| 08/28/1997 | WO1997019953A3 New lh-rh antagonists with improved effectiveness |
| 08/28/1997 | WO1997019702A3 Powdery iodine complexes |
| 08/28/1997 | WO1997019701A3 Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
| 08/28/1997 | WO1997019679A3 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 08/28/1997 | WO1997019669A3 Heterocyclic compounds and their use |
| 08/28/1997 | WO1997016535A3 Methods for use of mpl ligands with primitive human stem cells |
| 08/28/1997 | WO1997009297A3 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 08/28/1997 | WO1997009068A3 Interactive molecular conjugates |
| 08/28/1997 | DE19608278A1 Pharmazeutische Mittel enthaltend perfluoralkylhaltige Metallkomplexe, und ihre Verwendung in der Tumortherapie und interventioniellen Radiologie Pharmaceutical preparations containing perfluoroalkyl-containing metal complexes, and their use in tumor therapy and radiology interventioniellen |
| 08/28/1997 | DE19607096A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists |
| 08/28/1997 | DE19600939C1 Verfahren zur Trennung von IgG und IgA A method for separating IgG and IgA |
| 08/28/1997 | CA2247481A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases |
| 08/28/1997 | CA2247468A1 Selective d1 dopamine receptor agonists and partial agonists/antagonists |
| 08/28/1997 | CA2247461A1 Method and composition for inhibiting cellular irreversible changes due to stress |
| 08/28/1997 | CA2247327A1 Triterpene derivatives and remedies for liver diseases |
| 08/28/1997 | CA2247258A1 Method of treating alopecia |
| 08/28/1997 | CA2247253A1 Pharmaceutical agents that contain perfluoroalkyl-containing metal complexes and their use in tumour therapy and interventional radiology |
| 08/28/1997 | CA2247206A1 External preparation for curing lesioned tissues |
| 08/28/1997 | CA2247130A1 Benzothiophenes, and formulations and methods, using same |
| 08/28/1997 | CA2247025A1 Antipathogenic peptides and compositions comprising them |
| 08/28/1997 | CA2246721A1 Benzothiophenes, formulations containing same, and methods |
| 08/28/1997 | CA2246359A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | CA2246300A1 Cell-based assay |
| 08/28/1997 | CA2246051A1 Azabicyclic esters of carbamic acids useful in therapy |
| 08/28/1997 | CA2245811A1 Pyridinone thrombin inhibitors |
| 08/28/1997 | CA2245646A1 Synthetic hiv genes |
| 08/28/1997 | CA2244851A1 M-amidino phenyl analogs as factor xa inhibitors |
| 08/28/1997 | CA2242809A1 Peptide derivatives |
| 08/28/1997 | CA2242598A1 Quinolones and their therapeutic use |
| 08/28/1997 | CA2241142A1 Liposomal-viral dna complexes for treating disease |
| 08/28/1997 | CA2238478A1 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide |
| 08/28/1997 | CA2198574A1 Combination therapy to prevent bone loss-progesterone and estrogen agonists |
| 08/28/1997 | CA2198571A1 Use of (e)-1-¬4'-(2-alkylaminoethioxy)phenyl|-1-(3'-hydroxyphenyl)-2-phenylbut-1-enes in inhibiting pathological conditions |
| 08/28/1997 | CA2198561A1 1,1,2-triphenylbut-1-ene derivatives for treating alzheimer's disease |
| 08/28/1997 | CA2198534A1 Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists |
| 08/28/1997 | CA2197617A1 Antiarrhythmic agents |
| 08/28/1997 | CA2183217A1 Compounds for use in managing labour |
| 08/27/1997 | EP0791651A1 Method for the treatment of biological material |
| 08/27/1997 | EP0791594A2 2-Aryl-5,11-dihydro-6H-dipyrido 3,2-b:2',3'-e 1,4 diazepines and their use for the preparation of pharmaceutical compositions for the treatment of HIV infection |
| 08/27/1997 | EP0791592A2 Azetidines |
| 08/27/1997 | EP0791591A1 Benzothiophenes, formulations containing same, and methods |
| 08/27/1997 | EP0791590A1 Benzothiophenes, and formulations and methods using same |
| 08/27/1997 | EP0791588A1 Process for the preparation of derivatives of amino-ascorbic acid |
| 08/27/1997 | EP0791587A1 Process for the preparation of derivatives of amino-ascorbic acid |
| 08/27/1997 | EP0791580A2 Novel derivatives of 3-bromo and 3,3-dibromo-4-oxo-1-azetidines, processes for the preparation thereof and their use |
| 08/27/1997 | EP0791577A1 Ortho-substituted benzylguanidines, process for their preparation and their use as medicament or diagnostic agent as well as medicament containing them |
| 08/27/1997 | EP0791576A2 Leukotriene antagonistic benzoic acid derivatives |
| 08/27/1997 | EP0791356A1 Combinations of droloxifene with progestins for the treatment of osteoporosis |
| 08/27/1997 | EP0791355A1 Method of reducing tissue damage associated with ischemia |
| 08/27/1997 | EP0791298A1 Growth promotion in chickens |
| 08/27/1997 | EP0791072A1 Process for determining the activity of specific phosphotyrosine phosphatases and specific effectors thereof in intact cells |
| 08/27/1997 | EP0791065A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
| 08/27/1997 | EP0791060A2 Ribozyme analogs |
| 08/27/1997 | EP0791056A2 Lipid-splitting enzyme |
| 08/27/1997 | EP0791054A1 Porcine striatal cells and their use in treatment of neurological deficits due to neurodegenerative disease |
| 08/27/1997 | EP0791052A1 Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 08/27/1997 | EP0791007A1 Antifungal sordaridin derivatives |
| 08/27/1997 | EP0791006A2 Polyanionic benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 08/27/1997 | EP0791005A1 Smooth muscle cell proliferation inhibitors |
| 08/27/1997 | EP0791004A1 Acylated benzylglycosides as inhibitors of smooth muscle cell proliferation |
| 08/27/1997 | EP0790999A1 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments |
| 08/27/1997 | EP0790998A1 Azo derivatives of 5-aminosalicylic acid for treatment of inflammatory bowel disease |
| 08/27/1997 | EP0790997A2 6-ARYL PYRIDO( 2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION |
| 08/27/1997 | EP0790996A1 Pyridazinoquinoline compounds |
| 08/27/1997 | EP0790995A1 A method of treating urinary bladder dysfunctions |
| 08/27/1997 | EP0790994A1 Heterocycle substituted propenoic acid derivatives as nmda antagonists |
| 08/27/1997 | EP0790993A1 Nonpeptide endothelin antagonists |
| 08/27/1997 | EP0790992A1 A new physically stable solid form of a fluoroquinolone |
| 08/27/1997 | EP0790988A1 Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production |
| 08/27/1997 | EP0790987A1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
| 08/27/1997 | EP0790986A1 Aniline derivatives |
| 08/27/1997 | EP0790981A1 Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors |
| 08/27/1997 | EP0790977A1 Amine derivatives for treatment of skin disorders |
| 08/27/1997 | EP0790974A1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors |
| 08/27/1997 | EP0790829A1 Medicaments |
| 08/27/1997 | EP0790828A1 Use of phosphonoacetic or-formic acids against human herpes virus -7 (hhv-7) |
| 08/27/1997 | EP0790827A2 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy |
| 08/27/1997 | EP0790826A1 Dihydropyrimidines and uses thereof |
| 08/27/1997 | EP0790825A1 Nk-1 receptor antagonists for the treatment of eye disorders |
| 08/27/1997 | EP0790824A1 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance |
| 08/27/1997 | EP0790769A1 Eleutherobin and analogs thereof |
| 08/27/1997 | EP0767660A4 Methods and formulations for modulating the human sexual response |
| 08/27/1997 | EP0745090B1 Oligonucleotides with anti-respiratory syncytial virus activity |
| 08/27/1997 | EP0725784B1 DIBENZO[b,e]OXEPINE DERIVATIVES, PROCESS FOR PRODUCING THEM AND MEDICAMENTS CONTAINING THEM |
| 08/27/1997 | EP0683788B1 3'-aziridino-anthracycline derivatives |
| 08/27/1997 | EP0681476B1 Unit dose form of bismuth subsalicylate |
| 08/27/1997 | EP0679152B1 Anti-androgenic cyclo and bicyclo alkenes |
| 08/27/1997 | EP0647231B1 N-substituted 3-azabicyclo[3.2.0]heptane derivatives useful as neuroleptic agents, etc. |
| 08/27/1997 | EP0637966B1 Bystander effect tumoricidal therapy |
| 08/27/1997 | EP0625967B1 N,n'-substituted imidocarbonimidic diamides derived from hydroxylamines |
| 08/27/1997 | EP0607231B1 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases |
| 08/27/1997 | EP0592438B1 Indole derivatives |
| 08/27/1997 | EP0575496B1 Cosmetic or pharmaceutical, especially dermatological, composition,containing oxyacanthine, in particular for stimulating hair growth or retarding hair loss |
| 08/27/1997 | EP0575454B1 Use of cucurbitine for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergic composition and method involving application thereof |
| 08/27/1997 | EP0567469B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES |
| 08/27/1997 | EP0560845B1 Cell proliferation matrix and use thereof |
| 08/27/1997 | EP0544895B1 Method for inactivating pathogens in a body fluid |